₹29.02 Crores | Listing at NSE | Wed, Dec 7, 2022 - Mon, Dec 19, 2022
Ajooni Biotech Limited Rights Issue comprises 4.84 Cr equity shares aggregating to ₹29.02 Cr, offered at an issue price of ₹6 per share with a face value of ₹2 per share.
The record date for determining eligible shareholders is Nov 25, 2022.
The term of payment is defined as following : The full amount of Issue Price Rs. 6 per Rights Equity Share is payable on Application.
The Rights Entitlements are expected to be credited to eligible demat accounts on Dec 23, 2022.
The Rights Issue opens on Dec 7, 2022, and closes on Dec 19, 2022, with renunciation of Rights Entitlements permitted up to Dec 9, 2022.
The deemed date of allotment is Dec 23, 2022, following which the equity shares are expected to be credited to demat accounts on Dec 27, 2022 and listed at the NSE on Dec 28, 2022.
Cameo Corporate Services Ltd. is the Registrar to the Issue.
Investors are advised to refer to the Ajooni Biotech Limited Letter of Offer for detailed information, including risk factors, issue terms, and procedural details.
Record Date
Fri, Nov 25, 2022
Entitlement Ratio
:
Open Date
Wed, Dec 7, 2022
Close Date
Mon, Dec 19, 2022
The full amount of Issue Price Rs. 6 per Rights Equity Share is payable on Application.
| Period Ended | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 31-Mar-20 | 2.31 | 40.09 | 0.35 |
| 31-Mar-21 | 28.03 | 51.06 | 0.37 |
| 31-Mar-22 | 29.02 | 74.08 | 1.05 |
| Amount in ₹ Crore | |||
Ajooni Biotech Limited is a Manufacturer of Cattle Feed and Feed Supplements. The company is a leading Cattle Feed and supplement Manufacturer in India. With the company's feed range, AJOONI is a rising key player in Animal Feed and aquaculture industry.
The company's product portfolio includes (i) Cattle Feeds such as Milk Boosters, Natural Calf Starters, Energy products etc. and (ii) Feed Supplements.
The details of the objects of the Issue are set out below:
1. TO PART FINANCE WORKING CAPITAL REQUIREMENTS OF THE COMPANY.
2. TO FINANCE THE GENERAL CORPORATE PURPOSE.
[Dilip Davda] Based on its recent financial performance, the issue appears fully priced. It has shown inconsistency in its top and bottom lines. Promoters’ holding declined from 52.62% to 32.41% in Sept. 22 quarter which raises major concern. The counter is well-managed above the RI price to lure investors. Well-informed, cash surplus risk seekers may consider investing in this fully priced offer. Read detail review...
Ajooni Biotech Limited
D-118, Industrial Area,
Phase-7, Mohali,
Punjab – 160059
Un, Gujarat, 160059
The Ajooni Biotech Rights Issue 2022 opens on Wed, Dec 7, 2022, and closes on Mon, Dec 19, 2022.
Ajooni Biotech Rights Issue 2022 Schedule
| Last Date for credit of Rights Entitlements | Tue, Dec 6, 2022 |
| Last Date for renunciation of Rights Entitlements | Fri, Dec 9, 2022 |
| Issue Opening Date | Wed, Dec 7, 2022 |
| Issue Closing Date | Mon, Dec 19, 2022 |
| Date of Allotment (on or about) | Fri, Dec 23, 2022 |
| Date of Credit (on or about) | Tue, Dec 27, 2022 |
| Date of Listing (on or about) | Wed, Dec 28, 2022 |
You can apply for Ajooni Biotech Rights Issue 2022 in two ways:
Steps to apply for Ajooni Biotech Rights Issue 2022 using Net Banking (ASBA)
Steps to apply for Ajooni Biotech Rights Issue 2022 using Registrar's website (R-WAP)
